Ravi Viswanathan

801 total citations
31 papers, 550 citations indexed

About

Ravi Viswanathan is a scholar working on Physiology, Immunology and Rheumatology. According to data from OpenAlex, Ravi Viswanathan has authored 31 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 11 papers in Immunology and 10 papers in Rheumatology. Recurrent topics in Ravi Viswanathan's work include Asthma and respiratory diseases (11 papers), Urticaria and Related Conditions (9 papers) and Allergic Rhinitis and Sensitization (8 papers). Ravi Viswanathan is often cited by papers focused on Asthma and respiratory diseases (11 papers), Urticaria and Related Conditions (9 papers) and Allergic Rhinitis and Sensitization (8 papers). Ravi Viswanathan collaborates with scholars based in United States. Ravi Viswanathan's co-authors include William W. Busse, Sameer K. Mathur, Bjoern Buehring, Neil Binkley, Mark Biagtan, Mark H. Moss, Robert K. Bush, William Busse, Daniel L. Rosenberg and Chewe Luo and has published in prestigious journals such as CHEST Journal, Journal of Allergy and Clinical Immunology and Advances in experimental medicine and biology.

In The Last Decade

Ravi Viswanathan

30 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ravi Viswanathan United States 12 256 151 116 96 93 31 550
Alexandra G. Ellis United States 13 118 0.5× 52 0.3× 161 1.4× 64 0.7× 39 0.4× 22 476
Avani Joshi United States 13 97 0.4× 68 0.5× 39 0.3× 314 3.3× 397 4.3× 35 939
M. Tauber France 16 155 0.6× 23 0.2× 191 1.6× 156 1.6× 319 3.4× 63 837
Andrea L. Pozez United States 11 134 0.5× 27 0.2× 121 1.0× 47 0.5× 297 3.2× 27 668
E. Archier France 10 46 0.2× 81 0.5× 87 0.8× 43 0.4× 398 4.3× 15 739
J.M. Norian United States 15 70 0.3× 49 0.3× 19 0.2× 49 0.5× 39 0.4× 33 1.0k
Saling Huang United States 10 115 0.4× 187 1.2× 14 0.1× 12 0.1× 107 1.2× 14 580
Christian Schulz Germany 17 180 0.7× 612 4.1× 39 0.3× 9 0.1× 185 2.0× 61 1.0k
Bas Zwart Netherlands 12 57 0.2× 39 0.3× 20 0.2× 50 0.5× 311 3.3× 13 734

Countries citing papers authored by Ravi Viswanathan

Since Specialization
Citations

This map shows the geographic impact of Ravi Viswanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Viswanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Viswanathan more than expected).

Fields of papers citing papers by Ravi Viswanathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Viswanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Viswanathan. The network helps show where Ravi Viswanathan may publish in the future.

Co-authorship network of co-authors of Ravi Viswanathan

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Viswanathan. A scholar is included among the top collaborators of Ravi Viswanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Viswanathan. Ravi Viswanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Viswanathan, Ravi, et al.. (2023). Phenotypes and Endotypes in Asthma. Advances in experimental medicine and biology. 1426. 119–142. 6 indexed citations
2.
Busse, William W. & Ravi Viswanathan. (2022). What has been learned by cytokine targeting of asthma?. Journal of Allergy and Clinical Immunology. 150(2). 235–249. 29 indexed citations
3.
Lee, Kristine E., et al.. (2022). Omalizumab for treatment of idiopathic angioedema. Annals of Allergy Asthma & Immunology. 129(5). 605–611.e1. 6 indexed citations
4.
5.
Kakumanu, Sujani, et al.. (2022). Outcomes from New Consultations to Allergy Clinic for COVID-19 Vaccine Concerns. Journal of Allergy and Clinical Immunology. 149(2). AB97–AB97. 2 indexed citations
6.
Viswanathan, Ravi & William W. Busse. (2020). How to compare the efficacy of biologic agents in asthma. Annals of Allergy Asthma & Immunology. 125(2). 137–149. 11 indexed citations
7.
Rosenberg, Daniel L., Sameer K. Mathur, & Ravi Viswanathan. (2019). Characterization of idiopathic angioedema in a university-based allergy/immunology practice. Annals of Allergy Asthma & Immunology. 123(4). 403–404. 1 indexed citations
8.
Viswanathan, Ravi, et al.. (2018). Clinical Characteristics of Patients in Allergy Clinic with Presumed Diagnosis of Mast Cell Activation Syndrome (MCAS). Journal of Allergy and Clinical Immunology. 141(2). AB50–AB50. 3 indexed citations
9.
Viswanathan, Ravi, et al.. (2016). Clinical Social Franchising Compendium, An annual survey of programs: findings from 2015. 17 indexed citations
10.
Biagtan, Mark, Ravi Viswanathan, & Robert K. Bush. (2014). Immunotherapy for House Dust Mite Sensitivity: Where Are the Knowledge Gaps?. Current Allergy and Asthma Reports. 14(12). 482–482. 36 indexed citations
11.
Mathur, Sameer K. & Ravi Viswanathan. (2014). Relevance of Allergy in Adult Asthma. Current Allergy and Asthma Reports. 14(5). 437–437. 14 indexed citations
12.
Buehring, Bjoern, Ravi Viswanathan, Neil Binkley, & William W. Busse. (2013). Glucocorticoid-induced osteoporosis: An update on effects and management. Journal of Allergy and Clinical Immunology. 132(5). 1019–1030. 120 indexed citations
13.
Viswanathan, Ravi, Mark Biagtan, & Sameer K. Mathur. (2012). The role of autoimmune testing in chronic idiopathic urticaria. Annals of Allergy Asthma & Immunology. 108(5). 337–341.e1. 34 indexed citations
14.
Viswanathan, Ravi, René Ekpini, Upjeet Chandan, et al.. (2012). Informing policy and programme decisions for scaling up the PMTCT and paediatric HIV response through joint technical missions. Health Policy and Planning. 28(4). 367–374. 6 indexed citations
15.
Viswanathan, Ravi & William W. Busse. (2012). Allergen Immunotherapy in Allergic Respiratory Diseases. CHEST Journal. 141(5). 1303–1314. 34 indexed citations
16.
Viswanathan, Ravi, Mark Biagtan, & Sameer K. Mathur. (2012). Autoimmune Profiling in Chronic Idiopathic Urticaria -- Is there Utility or Futility?. Journal of Allergy and Clinical Immunology. 129(2). AB224–AB224. 1 indexed citations
17.
Viswanathan, Ravi & Sameer K. Mathur. (2011). Role of Allergen Sensitization in Older Adults. Current Allergy and Asthma Reports. 11(5). 427–433. 16 indexed citations
18.
Viswanathan, Ravi, et al.. (2011). What effect does asthma treatment have on airway remodeling? Current perspectives. Journal of Allergy and Clinical Immunology. 128(3). 439–448. 131 indexed citations
19.
Biagtan, Mark, Ravi Viswanathan, & Sameer K. Mathur. (2011). The Chronic Urticaria Index as a Predictor of Responsiveness to Therapy. Journal of Allergy and Clinical Immunology. 127(2). AB104–AB104. 1 indexed citations
20.
Viswanathan, Ravi, et al.. (1966). Fluphenazine Enanthate in the Maintenance Treatment of Schizophrenia. BMJ. 2(5524). 1262–1262. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra G. Ellis Breakdown of academic impact, for papers by Avani Joshi Breakdown of academic impact, for papers by M. Tauber Breakdown of academic impact, for papers by Andrea L. Pozez Breakdown of academic impact, for papers by E. Archier Breakdown of academic impact, for papers by J.M. Norian Breakdown of academic impact, for papers by Saling Huang Breakdown of academic impact, for papers by Christian Schulz Breakdown of academic impact, for papers by Bas Zwart
Rankless by CCL
2026